Ashley D. is currently the Director of Global Labelling Strategy at AstraZeneca and previously held a similar role at GSK. With a strong background in regulatory affairs, Ashley has worked at Allergan as a Manager and Senior Analyst, contributing to drug development projects and ensuring compliance with European regulations. Ashley gained initial experience at Pfizer, focusing on EU regulatory strategy during an industrial trainee placement. A graduate of the University of Warwick, Ashley holds a First Class Honours degree in Biological Sciences.
This person is not in any teams
This person is not in any offices